Two of the most closely watched Alzheimer clinical trials of the decade have delivered a sobering verdict: GLP-1 drugs that revolutionized diabetes and weight loss did not slow the disease’s ...
While the drug was safe and improved some biological markers linked to the disease, it did not slow memory or cognitive decline compared to a placebo. HealthDay News — A pill version of semaglutide, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results